Welireg outperformed Afinitor in time to disease progression and patient-reported quality of life in the treatment of metastatic clear cell renal cell carcinoma. Patients with advanced or metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback